Home
Novavax NVAX spent $110K on lobbying in Q1 2023 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $110,000
- Quarter
- Q1 2023
- Stock
- Novavax NVAX
- Client
- Novavax
- Reported
- 23/04/20
Down 26.7% from last quarter
What else happened in Novavax around then
Filed or reported within 30 days of the trade day · 23/03/01~23/04/30Novavax's other lobbying reports
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$130K
$130K
Reported 07/17
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/16
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/15
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$140K
$140K
Reported 04/20
for Q1
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 04/16
for Q1